Antibodies for Cancer Research

Request Information

Related Resources: Brochures | Application Notes

Your search ends here.

Cancer research is dependent upon reliable antibodies and assays for interrogating and identifying the phenotypic differences between cancer cells and corresponding normal cells of the same lineage. The recent output of data from genomic, proteomic, and epigenomic studies comparing tumor and non-tumor cells points to several key traits or “hallmarks”, shared by most tumor types, that drive disease progression.

With Merck’s comprehensive portfolio, including the Upstate®, Chemicon®, and Calbiochem® brands of reagents and antibodies, researchers can count on dependable, high quality solutions for analyzing the hallmarks of cancer.

Explore antibodies for cancer research by searching for your target in the “search box” or browsing the topics below.

Browse All Cancer Antibodies

New Cancer Guide
Merck:/Freestyle/BI-Bioscience/Antibodies-Assays/Cancer_Research_Solutions_Guide.jpgExplore the 10 hallmarks of cancer in the Cancer Research Tools guide.

Download Now 


Download the Cancer-Signaling Antibodies Flyer:
Merck:/Freestyle/BI-Bioscience/Antibodies-Assays/cancer-images/reputable-cancer-cover.jpgOur top published complementing primary and secondary antibodies

Download Now 

Find Primary Antibodies

Enter a keyword and/or search criteria below. Or you may also use selections below to browse specific antibodies for your needs.

 

Pick Your Topic, Find Your Antibody

Apoptosis
Apoptosis
Apoptosis, or programmed cell death, is regulated by a variety of proteins, including cell surface receptors, adaptors, proteases and mitochondrial components. Mutations of these proteins may tip the balance, resulting in the uncontrolled survival and proliferation of cancer cells.
More...
Therefore, the study of cancer depends on having a reliable source of validated antibodies for apoptosis proteins. Apoptosis involves processes including DNA damage (mutation), caspase activation, mitochondrial pathways, phosphatidylserine translocation, and annexin V binding. Merck offers a wide selection of validated antibodies for apoptosis-related proteins and associated proteins.
Related Products:

Autophagy
Autophagy
Autophagy is a highly regulated homeostatic degradative process in which cells destroy and recycle their own components via the lysosomal machinery.
More...
This process is associated with a diverse range of diseases, including Alzheimer’s disease, aging, cancers and autoimmune diseases. On one hand, autophagy may induce cell death by degrading essential components; on the other hand, it may facilitate survival of cancer cells under unfavorable metabolic conditions or allow cancer cells to survive chemotherapy by employing a protective autophagic process. Merck provides validated antibodies against key proteins of the autophagy signaling pathway, including LC3, various ATG family members, and more.
Related Products:

Angiogenesis
Angiogenesis
Angiogenesis, the development of new capillary blood vessels and vascular networks, is rare in adult tissues. In tumors, dysregulated signaling and hypoxic conditions lead to sustained, almost uncontrolled angiogenesis.
More...
Antibodies for angiogenesis proteins are useful for distinguishing tumor from non-tumor, because of the multiple differences between tumor angiogenesis and normal blood vessel formation. Merck has a variety of antibodies, inhibitors, proteins and kits to study angiogenesis, whether you want to induce or inhibit the formation of new blood vessels.
Related Products:

Metastasis
Metastasis
Metastasis results from multiple changes in tumor cells and their microenvironment.
More...
Such changes enable tumor cells to invade tissue (invasion), enter blood vessels (intravasation), circulate to new locations, exit blood vessels (extravasation), form new tumors, and establish new blood supply (angiogenesis). Merck has a robust portfolio of validated antibodies and assay kits to advance your cancer research and to investigate the mechanisms underlying metastasis.
Related Products:

    Cancer
    Stem Cells
    Cancer  Stem Cells
    Cancer stem cells (CSCs) are a subpopulation of cancer cells that have stem cell capabilities and can self-renew, generate diverse cells in the tumor mass, and sustain tumor growth.
    More...
    Cancer may be the result of mutation induced proliferative abilities in normal stem cells. CSCs may thus drive tumor progression and recurrence, even after treatments such as chemotherapy have been administered. Stem cells display a specific set of proteins that allow their detection and separation from differentiated cells. Merck provides validated antibodies against key cancer stem cell proteins, including, Notch, Wnt, Shh, Oct-4, Sox-2, Nanog and more.
    Related Products:
     
     

    Related Solutions

    Related Technologies


    Antibodies Home Page